Tami Martin, R.N.
2020
Compensation breakdown
Non-Equity Incentive Plan | $131,200 |
---|---|
Option Awards | $309,438 |
Salary | $326,401 |
Other | $37,598 |
Total | $804,637 |
RN received $326.4K in salary, accounting for 41% of the total pay in 2020.
RN also received $131.2K in non-equity incentive plan, $309.4K in option awards and $37.6K in other compensation.
Rankings
In 2020, Tami Martin, R.N.'s compensation ranked 9,481st out of 13,090 executives tracked by ExecPay. In other words, RN earned more than 27.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 9,481 | 28th |
Manufacturing | 4,061 | 28th |
Chemicals And Allied Products | 1,653 | 27th |
Drugs | 1,449 | 26th |
Pharmaceutical Preparations | 1,066 | 27th |
Pay ratio
Tami Martin, R.N.'s Pay | $804,637 |
---|---|
Median Employee's Pay | $148,804 |
Pay Ratio | 5to 1 |
In 2020, the annual total compensation of Tami Martin, R.N. was $804,637.
The annual total compensation of the median employee at Supernus Pharmaceuticals was $148,804.
The ratio of Tami Martin, R.N.'s pay to the pay of median employee was therefore 5 to one.
RN's colleagues
We found five more compensation records of executives who worked with Tami Martin, R.N. at Supernus Pharmaceuticals in 2020.
2020
Jack Khattar
Supernus Pharmaceuticals
Chief Executive Officer
2020
James Kelly
Supernus Pharmaceuticals
Chief Financial Officer
2020
Stefan Schwabe
Supernus Pharmaceuticals
Chief Medical Officer
2020
Gregory Patrick
Supernus Pharmaceuticals
Chief Financial Officer
2020
Padmanabh Bhatt
Supernus Pharmaceuticals